Spain's Oryzon Bucks Trend To Seek NASDAQ Listing
While Raising Cash For Cancer and CNS Drugs
Executive Summary
The year to date has been a depressing period for initial public offerings, especially in Europe, but the Madrid-based epigenetics specialist is evaluating whether to head west and list in the US.